Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19).

Smith, Alison G C; Wilber, Eli; Rebolledo, Paulina A; Sharp, Joseph; Kandiah, Sheetal; Graciaa, Daniel S; Kempker, Russell R

Smith, Alison G C; Wilber, Eli; Rebolledo, Paulina A; Sharp, Joseph; Kandiah, Sheetal; Graciaa, Daniel S; Kempker, Russell R.

Afiliação

Smith AGC; Emory University School of Medicine, Atlanta, Georgia.
Wilber E; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Rebolledo PA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Sharp J; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Kandiah S; Division of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Graciaa DS; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Kempker RR; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Antimicrob Steward Healthc Epidemiol ; 2(1)2022.

Article em En | MEDLINE | ID: mdl-35601658

ABSTRACT

ABSTRACT

We assessed the prevalence of antibiotic prescriptions among ambulatory patients tested for coronavirus disease 2019 (COVID-19) in a large public US healthcare system and found a low overall rate of antibiotic prescriptions (6.7%). Only 3.8% of positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests were associated with an antibiotic prescription within 7 days.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Antimicrob Steward Healthc Epidemiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Geórgia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google